Stock data
Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. (VERA) reported net income of -US$299.62M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$315.47M | -US$299.62M | — |
| 2024 | — | — | -US$167.17M | -US$152.15M | — |
| 2023 | — | — | -US$102.01M | -US$95.99M | — |
| 2022 | — | — | -US$90.90M | -US$89.06M | — |
| 2021 | — | — | -US$34.40M | -US$32.61M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$109.47M | — |
| 2026-03-31 | — | -US$121.03M | — |
| 2025-12-31 | — | -US$91.10M | — |
| 2025-09-30 | — | -US$80.29M | — |
| 2025-06-30 | — | -US$76.53M | — |
| 2025-03-31 | — | -US$51.69M | — |
| 2024-12-31 | — | -US$43.42M | — |
| 2024-09-30 | — | -US$46.63M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.